Uğur Yılmaz1, Erkut Küçük1, Arzu Ülgen2, Ayse Özköse3, Suleyman Demircan3, Dondu M Ulusoy3, Gökmen Zararsız4. 1. Ophthalmology Department, Niğde State Hospital, Niğde-Turkey. 2. Psychiatry Department, Nigde State Hospital, Niğde -Turkey. 3. Ophthalmology Department, Kayseri Training and Research Hospital, Kayseri - Turkey. 4. Deparment of Biostatistics, Erciyes University Faculty of Medicine, Kayseri - Turkey.
Abstract
PURPOSE: To investigate the retina and macular thickness in patients with schizophrenia and to compare the results with those of healthy controls. METHODS: Sixty-eight eyes of 34 patients with schizophrenia and 60 eyes of 30 randomly selected healthy volunteers were involved in the study. Measurements of peripapillary retinal nerve fiber layer (RNFL) thickness, macula thickness, and macula volume were taken in both eyes using spectral-domain optical coherence tomography (OCT). Statistical analysis was performed using Statistical Package for the Social Sciences version 20.0. RESULTS: Average and nasal RNFL thicknesses were found to be significantly lower in the patient group than the control group (p = 0.030, p = 0.04, respectively). Macular thicknesses of nasal outer and inferior outer quadrants in the patient group were significantly lower than in the control group (p = 0.009, p = 0.027, respectively). Average macular thickness and macular thicknesses in the superior outer, superior inner, temporal outer, temporal inner, nasal inner, and inferior inner areas were lower in the patient group compared to the control group, but not significantly (p = 1.000, p = 1.000, p = 0.837, p = 1.000, p = 0.279, p = 1.000, p = 0.180, respectively). CONCLUSIONS: We detected RNFL and macular thinning in patients with schizophrenia. Based on these findings and results of other studies evaluating retina using OCT and brain magnetic resonance imaging studies in patients with schizophrenia, a neurodegenerative process may be an underlying pathologic mechanism in this disease.
PURPOSE: To investigate the retina and macular thickness in patients with schizophrenia and to compare the results with those of healthy controls. METHODS: Sixty-eight eyes of 34 patients with schizophrenia and 60 eyes of 30 randomly selected healthy volunteers were involved in the study. Measurements of peripapillary retinal nerve fiber layer (RNFL) thickness, macula thickness, and macula volume were taken in both eyes using spectral-domain optical coherence tomography (OCT). Statistical analysis was performed using Statistical Package for the Social Sciences version 20.0. RESULTS: Average and nasal RNFL thicknesses were found to be significantly lower in the patient group than the control group (p = 0.030, p = 0.04, respectively). Macular thicknesses of nasal outer and inferior outer quadrants in the patient group were significantly lower than in the control group (p = 0.009, p = 0.027, respectively). Average macular thickness and macular thicknesses in the superior outer, superior inner, temporal outer, temporal inner, nasal inner, and inferior inner areas were lower in the patient group compared to the control group, but not significantly (p = 1.000, p = 1.000, p = 0.837, p = 1.000, p = 0.279, p = 1.000, p = 0.180, respectively). CONCLUSIONS: We detected RNFL and macular thinning in patients with schizophrenia. Based on these findings and results of other studies evaluating retina using OCT and brain magnetic resonance imaging studies in patients with schizophrenia, a neurodegenerative process may be an underlying pathologic mechanism in this disease.
Authors: Fernando Caravaggio; Enzo Scifo; Etienne L Sibille; Sergio E Hernandez-Da Mota; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero Journal: Exp Eye Res Date: 2018-06-05 Impact factor: 3.467
Authors: Nikoleta Nikitova; Brian P Keane; Docia Demmin; Steven M Silverstein; Peter J Uhlhaas Journal: Schizophr Res Date: 2019-06-08 Impact factor: 4.939
Authors: Deepthi Bannai; Paulo Lizano; Megan Kasetty; Olivia Lutz; Victor Zeng; Suraj Sarvode; Leo A Kim; Scot Hill; Carol Tamminga; Brett Clementz; Elliot Gershon; Godfrey Pearlson; John B Miller; Matcheri Keshavan Journal: Psychiatry Res Neuroimaging Date: 2020-02-29 Impact factor: 2.376
Authors: Vicente Polo; Maria Satue; Alicia Gavin; Elisa Vilades; Elvira Orduna; Marta Cipres; Javier Garcia-Campayo; Mayte Navarro-Gil; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin Journal: Eye (Lond) Date: 2018-10-31 Impact factor: 3.775
Authors: Hannah Currant; Pirro Hysi; Tomas W Fitzgerald; Puya Gharahkhani; Pieter W M Bonnemaijer; Anne Senabouth; Alex W Hewitt; Denize Atan; Tin Aung; Jason Charng; Hélène Choquet; Jamie Craig; Peng T Khaw; Caroline C W Klaver; Michiaki Kubo; Jue-Sheng Ong; Louis R Pasquale; Charles A Reisman; Maciej Daniszewski; Joseph E Powell; Alice Pébay; Mark J Simcoe; Alberta A H J Thiadens; Cornelia M van Duijn; Seyhan Yazar; Eric Jorgenson; Stuart MacGregor; Chris J Hammond; David A Mackey; Janey L Wiggs; Paul J Foster; Praveen J Patel; Ewan Birney; Anthony P Khawaja Journal: PLoS Genet Date: 2021-05-12 Impact factor: 5.917